Newsletter
60% of health care workers surveyed believe the U.S. health care system is not effectively helping patients and their families navigate dementia care.
The Journey: From The Bridge
New drug candidate targeting synaptic resilience well tolerated in Alzheimer’s patients
A small clinical trial suggests that a new type of drug may be safe for people with Alzheimer’s disease and could potentially mitigate some of the brain damage caused by the condition. Findings from the NIA-funded study, published in Nature Medicine, support further research to assess the drug’s long-term safety and...
New drug candidate targeting synaptic resilience well tolerated in Alzheimer’s patients
A small clinical trial suggests that a new type of drug may be safe for people with Alzheimer’s disease and could potentially mitigate some of the brain damage caused by the condition. Findings from the NIA-funded study, published in Nature Medicine, support further research to assess the drug’s long-term safety and...
